Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

IBIS-II investigators

Research output: Contribution to journalArticlepeer-review

379 Citations (Scopus)
290 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences